Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Katharine Peterson Insider Profile
4 Followers
Katharine Peterson, CAO at Acrivon Therapeutics, Inc., holds 4.54K shares in Acrivon Therapeutics, Inc. (Ticker: ACRV).
Katharine Peterson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Katharine Peterson's holdings
Insider Roles
CAO
Roles that Katharine Peterson holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Katharine Peterson
Katharine Peterson's Trading History
List of latest transactions for each holding click on a transaction to see Katharine Peterson's performance on stock
You May Also Like
Katharine Peterson insider profile FAQ
What is the percentage of profitable transactions made by Katharine Peterson?
The percentage of profitable transactions made by Katharine Peterson is ―.
What is the average return per transaction made by Katharine Peterson?
The average return per transaction made by Katharine Peterson is ―.
What stocks does Katharine Peterson hold?
Katharine Peterson holds: ACRV stocks.
What was Katharine Peterson’s latest transaction?
Katharine Peterson latest transaction was an Uninformative Sell of $784.08.
What was Katharine Peterson's most profitable transaction?
Katharine Peterson’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Katharine Peterson's role in Acrivon Therapeutics, Inc.?
Katharine Peterson's role in Acrivon Therapeutics, Inc. is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.